Prozomix Limited, a global leader in biocatalyst discovery and production for pharma applications, becomes first biotech company to contribute to the Cali Fund. Following TierraViva AI’s first contribution at COP30, this step signals growing momentum for the world’s first multilateral mechanism for sharing the benefits of nature’s genetic data. It also highlights the role of small, innovative biotech companies in leading by example, setting the stage for the next contributions.
It also offers early evidence that the contribution process is working as designed. From initial engagement to funds received, the process moved forward in weeks. Coordination among the Steering Committee, the Multi-Partner Trust Fund Office, and Prozomix moved smoothly at every step, showing that the Cali Fund’s contribution architecture is operational and ready to receive more.
“With over twenty years of experience working in innovative biotech SMEs leveraging digital sequence information on genetic resources (DSI) to one extent or another, in my view such businesses at large would only benefit from contributing a fair share of their total revenue, be it sales of products or services,” said Simon Charnock, CEO of Prozomix.
Every contribution matters. Each one signals that a fair, transparent, and multilateral approach to benefit-sharing from nature’s genetic data is not only possible but underway.
As the Cali Fund heads toward COP17 in Armenia, we look forward to welcoming more companies ready to join Prozomix and TierraViva AI.
Read Prozomix’s statement about their contribution here: www.prozomix.com/cali-fund